anmelden
Novartis Aktie
130,56
EUR
-0,70
EUR
-0,53
%
122,44
CHF
-1,30
CHF
-1,05
%
Novartis jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Marktkap. 238,19 Mrd. EUR
KGV 18,30 Div. Rendite 3,38%WKN 904278
ISIN CH0012005267
Symbol NVSEF
AI Analyse
Werbung
Novartis Aktie Analyse
| 30.09.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 29.09.20 | Novartis buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.09.20 | Novartis Underweight | Barclays Capital | |
| 23.09.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 10.09.20 | Novartis buy | UBS AG | |
| 01.09.20 | Novartis overweight | Morgan Stanley | |
| 26.08.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 21.08.20 | Novartis Neutral | UBS AG | |
|
Werbung
|
|||
| 21.08.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 18.08.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 18.08.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 12.08.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.07.20 | Novartis neutral | Morgan Stanley | |
| 22.07.20 | Novartis Hold | HSBC | |
| 22.07.20 | Novartis Neutral | Credit Suisse Group | |
| 22.07.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 21.07.20 | Novartis Equal-Weight | Morgan Stanley | |
| 21.07.20 | Novartis Hold | Kepler Cheuvreux | |
| 21.07.20 | Novartis Neutral | UBS AG | |
| 21.07.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 21.07.20 | Novartis buy | Jefferies & Company Inc. | |
| 21.07.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.07.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 16.07.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.06.20 | Novartis Neutral | UBS AG | |
| 22.06.20 | Novartis buy | Oddo BHF | |
| 10.06.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.06.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 21.05.20 | Novartis Neutral | UBS AG | |
| 11.05.20 | Novartis Neutral | UBS AG | |
| 08.05.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 05.05.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.04.20 | Novartis Hold | HSBC | |
| 29.04.20 | Novartis Neutral | Credit Suisse Group | |
| 29.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | Novartis Neutral | UBS AG | |
| 28.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 28.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.04.20 | Novartis buy | Jefferies & Company Inc. | |
| 24.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.04.20 | Novartis buy | Jefferies & Company Inc. | |
| 07.04.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 07.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 06.04.20 | Novartis Hold | Deutsche Bank AG | |
| 02.04.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 01.04.20 | Novartis buy | Jefferies & Company Inc. | |
| 31.03.20 | Novartis buy | Oddo BHF | |
| 24.03.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 20.03.20 | Novartis Hold | Deutsche Bank AG | |
Werbung
Werbung
